Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Public rejection of “cloned” beef may seem like a knee-jerk reaction to a loaded work. But biotech has a problem that isn’t going away.
We may undergo plastic surgery for silly reasons, but anyone who has a brain would think twice before tampering with the body’s physical core.
Pharmaceuticals: The first batch of drugs derived from genomics is on the way.
Reviled in the ’80s and forgotten in the ’90s, the artificial heart is back and beating. TR readers get a rare glimpse inside the company that’s developing it.
Something is seriously amiss when “experts” identifying the century’s greatest journalism overlook coverage of science and technology.